While Pharvaris NV has underperformed by -2.18%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, PHVS fell by -9.59%, with highs and lows ranging from $29.80 to $11.51, whereas the simple moving average jumped by 18.77% in the last 200 days.
On October 15, 2025, H.C. Wainwright started tracking Pharvaris NV (NASDAQ: PHVS) recommending Buy. A report published by BofA Securities on October 09, 2025, Upgraded its rating to ‘Neutral’ for PHVS. Guggenheim also rated PHVS shares as ‘Buy’, setting a target price of $32 on the company’s shares in an initiating report dated June 11, 2025. Cantor Fitzgerald Initiated an Overweight rating on April 29, 2025, and assigned a price target of $28. Wedbush initiated its ‘Outperform’ rating for PHVS, as published in its report on September 25, 2023. Morgan Stanley’s report from August 15, 2023 suggests a price prediction of $34 for PHVS shares, giving the stock a ‘Overweight’ rating. Bryan Garnier also rated the stock as ‘Buy’.
Analysis of Pharvaris NV (PHVS)
Pharvaris NV’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of -51.81% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 12.86, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
The average volume for any stock is also a very valuable indicator of volatility, and PHVS has an average volume of 340.36K. On a monthly basis, the volatility of the stock is set at 6.07%, whereas on a weekly basis, it is put at 4.52%, with a loss of -3.09% over the past seven days. Furthermore, long-term investors anticipate a median target price of $45.89, showing growth from the present price of $25.09, which can serve as yet another indication of whether PHVS is worth investing in or should be passed over.
How Do You Analyze Pharvaris NV Shares?
In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 58.96%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 42.26% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
